Skip to content

Paracetamol Rectal Suppository for postoperative pain reduction in Abdominal Hysterectomy A Randomized controlled trial

Paracetamol Rectal Suppository for postoperative pain reduction in Abdominal Hysterectomy A Randomized controlled trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000531819
Enrollment
60
Registered
2012-05-21
Start date
2010-10-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Paracetamol in conjunction with strong opioids such as morphine shown to reduce the amount of opioid used and improve analgesic effect. Paracetamol has many available forms such as oral injection and suppository. In the first 24 hours after surgery, women were not allowed to have any ingestion, except intravenous solution. Therefore, paracetamol rectal suppository was add with strong opioids (morphine or pethidine) routinely postoperative painkillers for postoperative pain relief. The aims of adding paracetamol rectal suppository were to reduce opioids consumption and avoid their adverse effects, e.g. nausea and/or vomiting, orthostatic hypotension and respiratory compression. We therefore would like to study the effectiveness and safety of paracetamol rectal suppository in pain reduction in women undergoing total abdominal hysterectomy. We hypothesized that paracetamol rectal suppository can reduce postoperative pain in abdominal hysterectomy more effective than placebo. The primary outcome was postoperative pain score and the secondary outcome was volume of opioids consumption.

Interventions

Arm1: paracetamol rectal suppositories 40 mg/kg single dose (1 tab = 325 mg) immediately postoperation.

Sponsors

Khon Kaen Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Elective benign abdominal hysterectomy Age <70 years Body weight 30-80 kg

Exclusion criteria

paracetamol hypersensitivity Bleeding disorders Had underlying diseases Renal, hepatic dysfunction

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026